UNSPSC 51342314: Penciclovir sodium

This classification denotes a purine antagonist and antiviral agent with the molecular formula C10H14N5O3.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P06226385L, chemically known as 1,9-dihydro-2-amino-9-(4-hydroxy-3-(hydroxymethyl)butyl)-6h-purin-6-one monosodium salt but more generally known as penciclovir sodium, which bears US NIH Compound Identifier 656702. Most nations, for tariff and trade purposes, schedule penciclovir sodium under HS 29335995 and SITC 51576.

As of Q4 2014, PENCICLOVIR SODIUM remains US FDA's Preferred Term for this commodity. Penciclovir sodium bears US NLM identifiers UMLS ID C0719742 and NCI Concept Code C47656. SMILES: C1NC2C(=O)[N-]C(NC2N1CCC(CO)CO)N.[NA+].

UNSPSC 51342314 Penciclovir sodium is a Commodity code that appears misaligned with the state and local opportunities recently tagged under it. The recent solicitations—naloxone procurement, a therapeutic pharmacy initiative RFI, medical and first aid supplies for fire rescue, and generic pharmaceuticals through a cooperative purchasing vehicle—do not reference penciclovir sodium or antiviral medications specifically. Instead, the code's recent activity encompasses emergency medical supplies, naloxone (an opioid antagonist), over-the-counter products, and pharmaceutical distribution infrastructure. State and local buyers under this nominal code include county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), city fire departments (Tampa), and multistate cooperative purchasing alliances (MMCAP, administered by Minnesota Department of Administration). The mix reflects health systems, emergency response operations, and centralized procurement vehicles serving multiple jurisdictions rather than a narrow antiviral-focused supply chain.

Geographic activity centers on Florida, Texas, and the MMCAP multistate footprint (Minnesota, Oregon, and participating member states). Recent representative opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (due July 26, 2023, through the county's e-Procurement Portal); the Texas HHS Commission's RFI on direct-to-manufacturer prescriptions (response deadline April 3, 2026); the City of Tampa's ITB for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000.00 (due March 13, 2026, with a 5 percent bid discount set-aside for certified Small Local Business Enterprises); and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (due March 26, 2026, effective July 1, 2026). The code shows little relevant recent activity tied to penciclovir sodium procurement specifically; state and local pharmaceutical and medical supply buying under this tag reflects broader emergency response and generic pharmaceutical distribution rather than specialty antivirals.